Sarepta Therapeutics | SRPT - Credores Comerciais

Preço das Ações
16.84
Mudança Diária
0.18 1.08%
Mensal
-8.38%
Anual
-77.10%
Q1 Previsão
15.90




Credores Comerciais Alterar Data
Acadia Pharmaceuticals USD 10.9M 10.84M 2025-12
Agios Pharmaceuticals USD 18.36M 1.2M 2025-12
Alnylam Pharmaceuticals USD 115.72M 1.87M 2025-12
Amgen USD 20.89B 1.25B 2025-12
BioCryst Pharmaceuticals USD 15.83M 10.26M 2025-12
Biogen USD 432M 18.9M 2025-12
BioMarin Pharmaceutical USD 759.03M 39.41M 2025-12
Capricor Therapeutics 1.65M 1.06M 2025-12
Daiichi Sankyo JPY 568.5B 16.84B 2025-12
Eli Lilly USD 5.38B 1.12B 2025-12
Esperion Therapeutics USD 65.07M 12.44M 2025-12
Gilead Sciences USD 808M 226M 2025-09
Incyte USD 1.63B 1.46B 2025-12
Insmed USD 79.91M 316K 2025-12
Ionis Pharmaceuticals USD 14.33M 8.47M 2025-09
Moderna USD 317M 50M 2025-12
Nektar Therapeutics USD 15.56M 1.28M 2025-09
Neurocrine Biosciences USD 545.5M 425.6M 2025-12
Novavax USD 24.58M 9.35M 2025-12
Pfizer USD 5.02B 142M 2025-09
PTC Therapeutics USD 45.49M 8.87M 2025-12
Regeneron Pharmaceuticals USD 5.83B 4.93B 2025-12
Roche Holding CHF 5.78B 1.27B 2025-12
Sangamo BioSciences USD 10.74M 7.46M 2025-06
Sanofi EUR 22.93B 927M 2025-12
Sarepta Therapeutics USD 280.84M 186.83M 2025-12
Tectonic Therapeutic USD 1.48M 1.32M 2025-09
Ultragenyx Pharmaceutical USD 40.57M 6.33M 2025-09
Vertex Pharmaceuticals USD 3.43B 600.9M 2025-12